MP79-19 POPULATION BASED ANALYSIS OF RATES OF USE OF NOVEL HORMONAL AGENTS AT THE END-OF-LIFE IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER | NobleBlocks
Public
MP79-19 POPULATION BASED ANALYSIS OF RATES OF USE OF NOVEL HORMONAL AGENTS AT THE END-OF-LIFE IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER
Published in The Journal of Urology • Apr 1, 2020
Authors:
Jason Hu
,
Armen Aprikian
,
Marie Vanhuyse
Abstract
syndrome patients with statin use had better outcome in time to CRPC than patients without statin use.
